Feedback / Questions
CHS-0214 (etanercept biosimilar) - Coherus
Coherus: Investor Presentation
(Coherus)
-
Jul 9, 2016 -
Anticipated approval in EU for psoriasis and rheumatoid arthritis in H2 2017
Anticipated EU regulatory
•
Biosimilar • Psoriasis
http://investors.coherus.com/phoenix.zhtml?c=253655&p=irol-presentations
Jul 9, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious